Status:
COMPLETED
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer
Lead Sponsor:
Carol Fabian, MD
Collaborating Sponsors:
University of Alabama at Birmingham
Avon Foundation
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
A study to examine the correlations between methylation of various genes associated with breast cancer and proliferation and cytomorphology in breast epithelial cells acquired by random periareolar fi...
Detailed Description
A study to examine the correlation between gene promotor methylation and benign breast tissue proliferation and cytomorphology collected via random periareolar fine needle aspiration in postmenopausal...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- women at high risk of developing breast cancer determined by family or personal history
- willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies
- Exclusion criteria:
- exclude women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA
Exclusion
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
281 Patients enrolled
Trial Details
Trial ID
NCT00323908
Start Date
June 1 2005
End Date
November 1 2008
Last Update
May 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.